Upon auscultation of a client's heart rate, the nurse notes the rate to have an irregular pattern of 72 bpm. The nurse notifies the health care provider because the client is exhibiting signs of:

Choice A reason: Cyanosis, a bluish skin discoloration, indicates hypoxemia in COPD due to impaired gas exchange in damaged alveoli. While concerning, it is a common chronic symptom and not immediately life-threatening unless rapidly worsening. Decreased level of consciousness signals severe hypoxia affecting cerebral oxygenation, requiring urgent reporting over stable cyanosis.

Choice B reason: Wheezing results from airway obstruction in COPD, caused by bronchoconstriction and mucus accumulation, reducing airflow. It’s a chronic symptom managed with bronchodilators. While important, it does not indicate acute decompensation like decreased consciousness, which reflects critical cerebral hypoxia and requires immediate intervention to prevent brain damage.

Choice C reason: Decreased level of consciousness indicates severe hypoxia in COPD, as low oxygen saturation impairs cerebral function. Brain cells require constant oxygen for ATP production via aerobic metabolism. Hypoxia reduces cerebral perfusion, causing confusion or unresponsiveness, signaling a life-threatening emergency. This finding warrants immediate reporting to address acute respiratory failure.

Choice D reason: Frequent coughing in COPD results from mucus production and airway irritation, a common chronic symptom. It aids in clearing secretions but does not indicate acute decompensation. Unlike decreased consciousness, which reflects severe cerebral hypoxia, coughing is less urgent and managed with expectorants or airway clearance techniques, not immediate reporting.

Choice A reason: Administering eye drops to the lower conjunctival sac ensures optimal drug absorption and minimizes corneal irritation. The conjunctival sac, a mucous membrane, allows medication to spread across the eye surface, treating conjunctivitis by targeting bacterial or inflammatory processes. This method avoids systemic absorption via the nasolacrimal duct, enhancing local efficacy and safety.

Choice B reason: Dropping medication onto the cornea risks irritation or injury, as the cornea is a sensitive, avascular tissue responsible for light refraction. Conjunctivitis treatment requires medication to contact the conjunctiva, not the cornea directly. This method could cause discomfort and reduce drug efficacy, as it does not target the inflamed conjunctival tissue.

Choice C reason: The sclera by the outer canthus is not ideal for eye drop administration. The sclera, a tough connective tissue, has poor drug absorption compared to the conjunctival sac. Drops placed here may run off, reducing contact with the inflamed conjunctiva in conjunctivitis, leading to ineffective treatment and potential waste of medication.

Choice D reason: The sclera by the inner canthus is near the nasolacrimal duct, increasing the risk of systemic drug absorption rather than local treatment of conjunctivitis. Drops should target the lower conjunctival sac to ensure contact with the inflamed tissue, maximizing therapeutic effect while minimizing systemic side effects like tachycardia from certain medications.